MedPath

Visual Function After Implantation of AcrySof® Toric Lens

Phase 4
Terminated
Conditions
Cataract
Interventions
Device: AcrySof Toric Intraocular Lens
Registration Number
NCT01074606
Lead Sponsor
Alcon Research
Brief Summary

The objective of this study is to evaluate the postoperative visual function of Taiwanese patients following bilateral or unilateral AcrySof Toric Intraocular Lens (IOL) implantation.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
56
Inclusion Criteria
  • Prospective subjects should be adults and may be of any race and gender, and diagnosed with cataracts.
  • Subject must require extraction of cataracts followed by implantation of a posterior chamber intraocular lens.
  • All subjects must have between 0.75 - 2.0 Diopter (D) of astigmatism preoperatively as measured by keratometry readings.
  • For any second eye surgery in bilateral AcrySof Toric patients, it should be performed at least one week following the first eye implant but no longer than one month after the first implant.
Read More
Exclusion Criteria
  • Subjects with pre-existing conditions that could skew the results should be excluded from the Study.
  • AcrySof® Toric product inserts under "Precautions" for subject groups that should be excluded from this Study.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ToricAcrySof Toric Intraocular LensAcrySof Toric Intraocular Lens (IOL)
Primary Outcome Measures
NameTimeMethod
Postoperative Refractive CylinderPre-Operative Day, 1 Month Postoperative, 3 Month Postoperative
Secondary Outcome Measures
NameTimeMethod
Uncorrected distance visual acuity (UCDVA)Pre-Operative Day, 1 Month Postoperative, 3 Month Postoperative
Best corrected distance visual acuity (BDCVA)Pre-operative, 1 month postoperative, 3 months postoperative
© Copyright 2025. All Rights Reserved by MedPath